Haoxi Health Technology vs Inuvo
Inuvo reported revenue of $86 million in fiscal 2025, 1.6 times Haoxi Health Technology's $55 million in fiscal 2026. Haoxi Health Technology's revenue grew 67.1% in its latest year, and Inuvo's grew 2.9%. Haoxi Health Technology had an operating margin of -17.6%, against -7.8% at Inuvo. Their fiscal years end in different months (June 30 and December 31), so the periods don't line up exactly.
Side by side
| Haoxi Health Technology | Inuvo | |
|---|---|---|
| Latest fiscal year | FY2026, Jun 30, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $55M | $86M |
| Revenue growth | 67.1% | 2.9% |
| Revenue growth a year, last 5 years | — | 14.1% |
| Gross margin | 1.1% | 74.5% |
| Operating margin | −17.6% | −7.8% |
| Net margin | −17.4% | −5.9% |
| Free cash flow | — | −$3M |
| Free cash flow margin | — | −3.9% |
| Return on capital | — | −58.1% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 2,536.8% | 3.4% |
| Last close | $1.80 | $0.27 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $800,000, sold $0 | — |
| Piotroski F-score | — | 3 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Haoxi Health TechnologyInuvo
Operating margin
Percent of revenue
Haoxi Health TechnologyInuvo
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Haoxi Health TechnologyInuvo
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Haoxi Health Technology and Inuvo pages.